Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTS,S malaria vaccine coadministration with measles-rubella and yellow fever vaccines in 6- to 9-month-old infants
PACTR201602001483150Not yet recruiting
- Sponsor
- GSK
- Start
- Sep 2016
- Modality
- Small Molecules, Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Single-arm trial of RTS,S, MR-VAC, 17D yellow fever vaccine and vitamin a in malaria, sponsored by GSK. Primary endpoint: Anti-CS antibody titers. Planned start Sep 2016; status: not yet recruiting.
02
Drugs
RTS,SMR-VAC17D yellow fever vaccinevitamin a
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR201602001483150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201602001483150.